Jaguar Health Future Growth
Future criteria checks 2/6
Jaguar Health is forecast to grow earnings and revenue by 25.6% and 41.8% per annum respectively while EPS is expected to grow by 147.4% per annum.
Key information
25.6%
Earnings growth rate
147.4%
EPS growth rate
| Pharmaceuticals earnings growth | 21.6% |
| Revenue growth rate | 41.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 19 Jul 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 19 | -24 | N/A | -12 | 1 |
| 12/31/2024 | 13 | -30 | N/A | -20 | 1 |
| 6/30/2024 | 10 | -36 | -29 | -29 | N/A |
| 3/31/2024 | 10 | -38 | -30 | -30 | N/A |
| 12/31/2023 | 10 | -41 | -33 | -33 | N/A |
| 9/30/2023 | 11 | -40 | -33 | -32 | N/A |
| 6/30/2023 | 11 | -44 | -34 | -34 | N/A |
| 3/31/2023 | 11 | -42 | -37 | -35 | N/A |
| 12/31/2022 | 12 | -47 | -35 | -33 | N/A |
| 9/30/2022 | 11 | -54 | -37 | -36 | N/A |
| 6/30/2022 | 8 | -54 | -38 | -37 | N/A |
| 3/31/2022 | 6 | -59 | -36 | -36 | N/A |
| 12/31/2021 | 4 | -53 | -35 | -35 | N/A |
| 9/30/2021 | 5 | -50 | -30 | -30 | N/A |
| 6/30/2021 | 7 | -46 | -24 | -24 | N/A |
| 3/31/2021 | 10 | -42 | -18 | -18 | N/A |
| 12/31/2020 | 9 | -39 | -15 | -15 | N/A |
| 9/30/2020 | 8 | -35 | -14 | -14 | N/A |
| 6/30/2020 | 7 | -39 | -20 | -20 | N/A |
| 3/31/2020 | 5 | -45 | -21 | -21 | N/A |
| 12/31/2019 | 6 | -45 | -20 | -20 | N/A |
| 9/30/2019 | 6 | -48 | -22 | -22 | N/A |
| 6/30/2019 | 6 | -43 | -16 | -16 | N/A |
| 3/31/2019 | 5 | -34 | -17 | -17 | N/A |
| 12/31/2018 | 4 | -32 | -23 | -23 | N/A |
| 9/30/2018 | 4 | -41 | -23 | -23 | N/A |
| 6/30/2018 | 4 | -30 | -23 | -23 | N/A |
| 3/31/2018 | 4 | -24 | N/A | -19 | N/A |
| 12/31/2017 | 4 | -22 | N/A | -10 | N/A |
| 9/30/2017 | 3 | -5 | N/A | -7 | N/A |
| 6/30/2017 | 2 | -14 | N/A | -17 | N/A |
| 3/31/2017 | 1 | -17 | N/A | -15 | N/A |
| 12/31/2016 | 0 | -15 | N/A | -14 | N/A |
| 12/31/2015 | 0 | 5 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1JA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 1JA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 1JA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 1JA's revenue (41.8% per year) is forecast to grow faster than the German market (5.3% per year).
High Growth Revenue: 1JA's revenue (41.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 1JA's Return on Equity is forecast to be high in 3 years time